Innovative Medicines Initiative launches a new call
The Innovative Medicines Initiative (IMI) has launched a new Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.
The Call 7 includes the following topics:
- Validation of translational imaging methods in drug safety assessment (TRISTAN)
- Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases
- Pathological neuron-glia interactions in neuropathic pain
- Dry age-related macular degeneration: development of novel clinical endpoints for clinical trials with a regulatory and patient access intention
- A comprehensive ‘paediatric preclinical POC platform’ to enable clinical molecule development for children with cancer
Details of Call 7 here
Text of Call 7 here